EBS vs STE · rev $1.04B vs P/E 25, rev $5.46B
Emergent Biosolutions Inc (EBS) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
EBS currently screens at market cap $416.4M. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the EBS and STE stock pages for the full models.
Not investment advice.